Novel allosteric antagonists shed light on mglu[sub 5] receptors and CNS disorders.
Fabrizio Gasparini, Thomas E. Salt, Will P.J.M. Spooren
pág. 331
Histamine receptors are finally 'coming out.'.
Takehiko Watanabe, Henk Timmerman, Rob Leurs
pág. 337
A new model serves AMPA receptor trafficking.
Richard W.C. Wong, Nobutaka Hirokawa
pág. 340
A novel mechanism for the reuptake of CGRP.
Alessandro Lecci
pág. 340
A role for leptin in autoimmunity?
Luke O'Neil
pág. 341
Anti-cancer drug success emerges from molecular biology origins.
Katharine Pestell
pág. 342
Vascular biology researcher honoured.
Katharine Pestell
pág. 342
New targets for Crohn's disease.
Katharine Pestell
pág. 342
Katharine Pestell
pág. 342
Insurmountable AT[sub 1] receptor antagonism: the need for different antagonist binding states of the receptor.: the need for different antagonist binding states of the receptor.
Georges Vauquelin, Frederik Fierens, Ilse Verheijen
pág. 343
Glutamate signalling in the lung.
Kathleen Dickman, Sami I. Said, Richard D. Dey
pág. 344
Anandamide: some like it hot.: some like it hot.
Luciano de Petrocellis, Vincenzo Di Marzo, Tiziana Bisogno
pág. 346
pág. 350
Regulation of mglu[sub 7] receptors by proteins that interact with the intracellular C-terminus.
Kumlesh K. Dev, Shigetada Nakanishi, Jeremy M. Henley
pág. 355
Therapeutic implications of human endothelial nitric oxide synthase gene polymorphism.
Michael J. Mihm, Suvara Kimnite Wattanapitayakul, AnthonyP. Young
pág. 361
G-protein-coupled receptors and signaling networks: emerging paradigms.: emerging paradigms.
J. Silvio Gutkind, Maria Julia Marinissen
pág. 368
Proteomics--post-genomic cartography to understand gene function.
Soren Naaby-Hansen, Rainer Cramer, Michael D. Waterfield
pág. 376
pág. 385
Keith Norman
pág. 385
© 2001-2024 Fundación Dialnet · Todos los derechos reservados